LAB vs NIO · rev $174.4M vs rev $12.51B
Standard Biotools Inc (LAB) versus Nio Inc Class A ADR (NIO) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Nio Inc Class A ADR (NIO) is a auto manufacturers company listed on US.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported NIO revenue for 2025-12-31 was $12.51B. Net income was -$2.14B. Revenue was up 38.9% from 2024-12-31 to 2025-12-31. NIO currently screens at market cap $7.61B.
LAB currently screens at market cap $317.1M. NIO currently screens at market cap $7.61B.
Not investment advice. Open the LAB and NIO stock pages for the full models.
Not investment advice.